• HLA-B51 Genotyping for Behçet’s Disease
  • Lipase, Serum
  • Carcinoembryonic Antigen (CEA), Pancreatic Cyst Fluid
  • CALU Gene Mutation Analysis
  • Arsenic Fractionation, 24 Hour, Urine
  • PM-1 (PM-Scl) Antibody
  • Ethosuximide, Serum
  • Endometrial Stromal Tumors (EST), 7p15 (JAZF1), 6p21.32 (PHF1), 17p13.3 (YWHAE) Rearrangement, FISH, Tissue
  • Group A Streptococcus (Streptococcus pyogenes) Rapid with Reflex to Culture
  • Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Factor XIII (F13A1) V34L Genetic Variation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Factor XIII (F13A1) V34L Genetic Variation Analysis
Medical Test

Interpretation
Access to Factor XIII (F13A1) V34L Genetic Variation Analysis is restricted.
Loading...